Research is exploring the connection between metabolism, epigenetics, and the immune system in cancer, with studies investigating various molecular mechanisms and potential therapeutic targets. The tumor microenvironment and metabolic pathways, such as glycolysis and lactylation, are being examined for their roles in immunosuppression and therapy resistance. Investigations into these mechanisms are being conducted across different types of cancer, including thyroid cancer, glioma, and digestive system tumors.